Skip to content

Other

TRIFLUOROMETHYL DEHYDROLATANOPROST

Updated
15

Safety score · 0–100

Avoid

Derived from EU CosIng regulatory status, PubChem hazard data and published research. How we score.

About

A trifluorinated analogue of latanoprost, a prescription glaucoma drug. Prostaglandin analogues alter iris pigmentation and lash growth — these are drug effects, not cosmetic ones, and use here would be regulated as an unlicensed medicine.

Function

NOT REPORTED

Skin benefits

  • Pharmacological prostaglandin F2alpha-like activity — drug effect only

Known concerns

  • Prescription-only prostaglandin analogue
  • Iris pigment darkening and periocular skin pigmentation reported with class
  • Eyelash hypertrichosis
  • Inappropriate for cosmetic exposure

References

EU

EU CosIng database

European Commission cosmetic ingredient registry — regulatory status, restrictions, authorised functions.

Related others

15
1,2-Epoxybutane
Other
 15
1-Methoxy-2,4-diaminobenzene (2,4-Diaminoanisole - CI 76050) and its salts
Other
 15
2,3-XYLENOL
Other
 15
4,4'-Bi-o-toluidine dihydrochloride
Other
 15
4-Methyl-m-phenylenediamine (Toluene-2,4-diamine) and its salts
Other
 15
AMINOPHYLLINE
Other
 15
ASARUM SIEBOLDII ROOT WATER
Other
 15
BUTYL ACRYLATE
Other

Check your shelf

Find TRIFLUOROMETHYL DEHYDROLATANOPROST in your products.

Scan any cosmetic product with LuxSense to see if it contains TRIFLUOROMETHYL DEHYDROLATANOPROST and get a full ingredient breakdown with safety scores.

This profile is for educational purposes and does not constitute medical advice. Regulatory status and scientific understanding evolve — always read the physical product label and consult a healthcare professional for personal concerns.